Langeland LB, Salvesen O, Selle H et al.
Norwegian University of Science and Technology, Trondheim, Norway.
Int J Clin Pract 2012;66:741–7.
Editor’s note: The use of real-time continuous glucose monitoring (CGM) on a permanent or semipermanent basis has been shown to be beneficial in a number of clinical studies (both in insulin pump users and in those using multiple daily injections of insulin) in terms of reducing average glucose levels and hypoglycemia experience (J Cardiovasc Transl Res 2012;5:380–7). Such treatment, however, is expensive and invasive when used for longer time periods, and it requires use for ≥80% of the time in order to produce these benefits. The current authors, therefore, sought to evaluate the impact of short-term real-time CGM compared with slightly intensified finger-prick glucose monitoring.